In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 339 for your search:
Drug:  mitoxantrone hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 16 to 60
Sponsor: Other
Protocol IDs: MK1-95, NCT00180102
2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Other
Protocol IDs: AML_GT60_DD, NCT00180167
3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: LAL-Ph-2000, NCT00526305
4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDL-3-251, MSKCC-93131, NCI-V94-0469
5.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUGEN-SU101.035, CDR0000067275, SUGEN-990711, NCT00004071
6.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7841
7.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-MBDT-8085
8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor: NCI
Protocol IDs: SWOG-8040/43, SWOG-8043
9.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8203/04, SWOG-8204
10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 17
Sponsor:
Protocol IDs: GER-GPOH-AML-BFM-93, EU-93008
11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 35 to 80
Sponsor:
Protocol IDs: GER-AIO-02/92, EU-93010
12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 80 and under
Sponsor: Other
Protocol IDs: GER-AIO-01/92, EU-93011, NCT00002544
13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549
14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, T94-0040, NCT00002565
15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor:
Protocol IDs: CRC-TU-NH3003, EU-93028, NCT00002576
16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 56 and over
Sponsor: NCI
Protocol IDs: SWOG-9333
17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-9421
18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to physiologic 59
Sponsor: Other
Protocol IDs: MRC-LEUK-AML12, EU-95001, NCT00002658
19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 65
Sponsor: Other
Protocol IDs: YALE-HIC-7996, NCI-V95-0728
20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000064498, EORTC-06951, FRE-LALA-94, NCT00002700
21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 74
Sponsor:
Protocol IDs: EORTC-06952, ITA-GIMEMA-AIEOP-1, NCT00002701
22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 61 to 80
Sponsor: Other
Protocol IDs: EORTC-06954, ITA-GIMEMA-AML13, NCT00002719
23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MSKCC-96015A1, NCI-V96-0881, NCT00002766
24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: E-2493, E2493
25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IMMUNEX-31-0001, NCI-V96-0962
1     
New Search